Jeremy Warner, MD, MS, FAMIA, FASCO
hemoncwarner.bsky.social
Jeremy Warner, MD, MS, FAMIA, FASCO
@hemoncwarner.bsky.social
Professor of Medicine and Biostatistics at Brown University, Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS), CTO of HemOnc.org, co-founder of the COVID-19 and Cancer Consortium (CCC19), EIC of JCO CCI. Views my own.
Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics
ascopubs.org
November 5, 2025 at 11:03 PM
Kids or Adults: Reflections on Choosing a Path in Oncology | ASCO Connection connection.asco.org/do/kids-adul...
Kids or Adults: Reflections on Choosing a Path in Oncology
Dr. Elaine Fan shares considerations and personal reflections on choosing to purse the pediatric or adult oncology track to help guide trainees that are torn between the two.
connection.asco.org
October 16, 2025 at 9:39 PM
Exciting new article: Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @ascocancer.bsky.social
Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics
Advancements in oncology are accelerating in the fields of artificial intelligence (AI) and machine learning. The complexity and multidisciplinary nature of oncology necessitate a cautious approach to...
ascopubs.org
September 24, 2025 at 4:18 PM
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.
September 24, 2025 at 12:51 AM
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatic...
PURPOSETo evaluate a generative artificial intelligence (GAI) framework for creating readable lay abstracts and summaries (LASs) of urologic oncology research, while maintaining accuracy, completeness...
ascopubs.org
September 19, 2025 at 12:17 PM
Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI #mCODE
ASCO Publications
ascopubs.org
September 3, 2025 at 9:39 PM
Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
ASCO Publications
ascopubs.org
September 3, 2025 at 9:38 PM
Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics
The integration of artificial intelligence (AI) into health care promises transformative advancements in diagnostics, treatment, and operational efficiency. However, this transformation introduces sig...
ascopubs.org
August 27, 2025 at 5:26 PM
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Inf...
PURPOSEChemotherapy is the primary treatment for metastatic nonseminomatous germ cell tumors (mNSGCTs), but patients often encounter postchemotherapy residual disease. Accurate noninvasive methods are...
ascopubs.org
August 27, 2025 at 5:25 PM
Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics
PURPOSESocial Determinants of Health (SDoH) have a significant effect on health outcomes and inequalities. SDoH can be extracted from electronic health records (EHR) to aid policy development and rese...
ascopubs.org
July 30, 2025 at 7:54 PM
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics
PURPOSEThe development of colorectal liver metastases (CRLMs) is associated with poor prognosis, and recent data suggest that metastasis to the liver is associated with resistance to immunotherapy. We...
ascopubs.org
July 25, 2025 at 1:20 PM
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics
PURPOSEThe present study aimed to investigate the role of body composition as an independent image-derived biomarker for clinical outcome prediction in a clinical trial cohort of patients with relapse...
ascopubs.org
July 25, 2025 at 1:20 PM
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics
PURPOSEConsumer wearable devices provide new opportunities for measuring patterns of objective daily physical activity throughout cancer treatment. In addition to capturing step counts, these devices ...
ascopubs.org
July 16, 2025 at 6:09 PM
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics
PURPOSEPrevious studies have consistently reported disparities in electronic health record portal enrollment. Among patients enrolled in a portal, it is less clear whether there are disparities in usa...
ascopubs.org
July 16, 2025 at 6:08 PM
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
I heard this morning that my informatics colleague Dr. Atul Butte passed after a battle with cancer. He was a giant in the field & inspired many of us over his distinguished career. He was a passionate champion of the power of big data & his impact on our field is immeasurable. RIP Atul & thanks.
June 14, 2025 at 1:20 PM
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
May 31, 2025 at 4:05 PM
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
PURPOSETumor treating fields (TTFields) use alternating electric fields to disrupt cancer cell proliferation. Feasibility of TTFields therapy with gemcitabine/nab-paclitaxel was previously demonstrate...
ascopubs.org
May 31, 2025 at 4:02 PM
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
So…about AI’s energy use…

“…to create a five-second video, a newer AI model uses ‘about 3.4 million joules, more than 700 times the energy required to generate a high-quality image’. That's the equivalent of running a microwave for over an hour.”
Report: Creating a 5-second AI video is like running a microwave for an hour
That's a long time in the microwave.
mashable.com
May 22, 2025 at 5:04 PM
Telehealth and Emergency Department Use Among Commercially Insured, Medicaid, and Medicare Patients Receiving Systemic Cancer Therapy in Washington State After COVID-19 | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... @emiliemgunn.bsky.social
ASCO Publications
ascopubs.org
May 22, 2025 at 4:13 PM
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com
ASCO and Google create ‘walled garden’ AI tool for doctors to query group’s guidelines
ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without extraneous information.
www.statnews.com
May 21, 2025 at 5:55 PM
Reposted by Jeremy Warner, MD, MS, FAMIA, FASCO
Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
ASCO Publications
ascopubs.org
May 20, 2025 at 1:28 PM
Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
ASCO Publications
ascopubs.org
May 20, 2025 at 1:28 PM